RYTELO 188 mg/1
imetelstat sodium · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Geron Corporation
Rytelo (imetelstat sodium) is an injectable prescription medication administered intravenously that is used to treat certain blood disorders, specifically myelodysplastic syndromes. It works by targeting telomerase, an enzyme involved in cell growth.
Key Facts
- Brand Name
- RYTELO
- Generic Name
- imetelstat sodium
- NDC Code (Product)
82959-111- Manufacturer
- Geron Corporation
- Strength
- 188 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA217779
- Marketing Start
- 06/06/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is RYTELO used for?
Rytelo (imetelstat sodium) is an injectable prescription medication administered intravenously that is used to treat certain blood disorders, specifically myelodysplastic syndromes. It works by targeting telomerase, an enzyme involved in cell growth.
Is RYTELO a controlled substance?
RYTELO is not classified as a controlled substance by the DEA.
What is the generic name for RYTELO?
The generic name for RYTELO is imetelstat sodium. There are no other listed brand versions of imetelstat sodium.
What is the NDC code for RYTELO 188 mg/1?
The NDC (National Drug Code) for RYTELO 188 mg/1 is 82959-111, listed by Geron Corporation.
Other RYTELO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)